Cell Therapy Next Current Issue

The following articles appeared in the print edition of Cell Therapy Next.

Table of Contents

• Near the Nation’s Capital Lies a ‘House of Hope’
• CD22 Redirected Autologous T Cells for ALL
• Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP)
• Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma
• Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma
• Study of huCART19 for Very High-Risk (VHR) Subsets of Pediatric B-ALL
• Specific Peptide-Enhanced Affinity Receptor MAGE-A4 T Cells for Synovial Sarcoma
• Adjuvant Cytokine-Induced Killer Cell Therapy Improves Survival in Postoperative Breast Cancer
• Autologous Antigen-Loaded Vaccine Safe, Feasible for Neuroblastoma
• Induction radiation therapy before CAR-T reduces treatment-related toxicities
• Off-the-Shelf Natural Killer Cells Safe, Clinically Active for Advanced Merkel Cell Carcinoma
• FDA Grants CAR T-cell Therapy RMAT Designation for Multiple Myeloma
• FDA Restructures, Renames Office that Reviews Cancer Therapies
• National Academy of Medicine Elects New Members
• MD Anderson, Ziopharm Renew R&D Agreement to Include T-cell Receptor-Based Therapies
• T-cell Therapy Receives FDA’s Orphan Drug Status for Soft Tissue Sarcoma
• UCLA Opens Clinical Trial of Bispecific CAR T-cell Therapy for Advanced Lymphoma, Leukemia